Comparison of metaphase II oocytes after stimulation with recombinant follicle-stimulating hormone and urinary follicle-stimulating hormone in a pituitary down-regulation regimen

Fertility and Sterility

Volumn 78, Issue 3, 2002, Pages 639-641

  Lan, Kuo Chung ^a   Lin, Yi Chi ^a   Huang, Fu Jen ^a   Kung, Fu Tsai ^a   Hsieh, Chin Hsiung ^a   Chang, Shiuh Young ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; METAPHASE; OOCYTE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL;

FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; LEUPROLIDE; MALE; METAPHASE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; RECOMBINANT PROTEINS; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 0036733996     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03299-5     Document Type: Article

References (4)

1. Molecular biology and biochemistry of human recombinant follicular stimulating hormone (Puregon)
2. No detrimental effects in delaying initiation of gonadotropin administration after pituitary desensitization with gonadotropin-releasing hormone agonist
3. Influence of polyvinylpyrrolidone on the outcome of intracyoplasmic sperm injection
4. The role of LH in ovarian stimulation; exogenous LH: let's design the future